2006/013 NICE issues guidance on drug treatments for attention deficit hyperactivity disorder (ADHD)
The National Institute for Health and Clinical Excellence (NICE) today (22 March) issued guidance to the NHS in England and Wales on the use of methylphenidate, atomoxetine and dexamfetamine for treating attention deficit hyperactivity disorder (ADHD) in children and adolescents. This updates previous guidance (TA no. 13) issued in October 2000, which gave recommendations on methylphenidate only.
 |
2006/013 NICE issues guidance on drug treatments for attention deficit hyperactivity disorder (ADHD) 23 March 2006 (31.7Kb 11sec @ 28.8Kbps) |
